Dr. Anil K. Sood is Professor and Vice Chair for Translational Research in the Department of Gynecologic Oncology and Reproductive Medicine at the UT MD Anderson Cancer Center. He holds a joint appointment in Cancer Biology and is co-director of the Center for RNA Interference and Non-Coding RNA at the M. D. Anderson Cancer Center. He is also Director of the multi-disciplinary Blanton-Davis Ovarian Cancer Research Program and co-leads the Ovarian Cancer Moonshot Program.
Dr. Sood received his medical degree from the University of North Carolina, Chapel Hill. A major and consistent theme of his scientific research has been on understanding human cancer biology and converting lab discoveries into novel therapeutics. His research group has made several seminal research contributions in the fields of tumor microenvironment, nanomedicine, and neuroendocrine effects on cancer biology. Dr. Sood has received recognition for his research accomplishments including the Hunter Award, the Margaret Greenfield/Carmel Cohen Excellence in Ovarian Cancer Research Prize, and the GCF/Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher. He is an elected member of the American Society for Clinical Investigation (ASCI), the American Association for the Advancement of Science (AAAS), and the Association of American Physicians (AAP). Dr. Sood was selected as an American Cancer Society Research Professor in 2017.
Esmaiel Jabbari ▼
Professor, Chemical Engineering, Biomedical Engineering, University of South Carolina
Esmaiel Jabbari completed his Ph.D. in Chemical Engineering, Purdue University in 1993. He is Tenured Full Professor of Chemical and Biomedical Engineering at the University of South Carolina. He directs the Biomaterials, Tissue Engineering, and Drug Delivery Laboratory which specializes in 3D tissue models for engineering of skeletal tissues and targeted drug delivery to cancer stem cells.
Prof. Jabbari has received numerous awards for his research achievements including the Berton Rahn Award in 2012 from the AO Foundation and the Stephen Milam Award in 2008 from the Oral and Maxillofacial Surgery Foundation. He was elected to the College of Fellows of American Institute of Medical and Biological Engineering (AIMBE) in 2013. He is the author of >250 refereed articles and he has mentored >130 scholars. He serves as Academic Editor for PLOS ONE and he is the Programming Chair for Bionanotechnology theme of the Engineering in Medicine & Biology Society (EMBS).
DR. SEUNGPYO HONG ▼
Professor Pharmaceutical Sciences Division, School of Pharmacy, Carbone Comprehensive Cancer Center, School of Medicine and Public Health, University of Wisconsin Madison
Dr. Seungpyo Hong is Professor of Pharmaceutics in the Pharmaceutical Sciences Division, School of Pharmacy at the University of Wisconsin-Madison (UW-Madison). He also holds an appointment as Adjunct Professor in the College of Pharmacy at the University of Illinois at Chicago (UIC) and serves as Associate Editor for Nanomedicine: Nanotechnology, Biology and Medicine of Elsevier. He graduated from Hanyang University in Seoul, Korea with B.S. and M.S. degrees in polymer engineering in 1999 and 2001, respectively.
After working as a researcher at Korea Institute Science and Technology (KIST), he started his Ph.D. study at the University of Michigan working with his advisors Profs. Mark Banaszak Holl and James Baker, Jr. Dr. Hong graduated with his PhD in Macromolecular Science and Engineering in 2006 and joined MIT as a postdoctoral associate in the laboratory of Prof. Robert Langer. From 2008 to 2014, he was Assistant Professor at UIC where he was promoted to Associate Professor in 2014, and subsequently joined the UW-Madison faculty as Professor in 2016.
Since 2008, he has led a research group under the major research theme of “Biomimetic Nanotechnology” for cancer treatment. To date, Prof. Hong’s research has culminated in over 68 peer-reviewed articles that have combined total citations of ~10,000 times, 7 book chapters, and 15 issued or pending patents
DR. Abhijit Date ▼
Assistant Professor of Pharmaceutical Sciences, Daniel K. Inouye College of Pharmacy, University of Hawaii Hilo
Abhijit Date, M.Pharm., Ph.D. is an Assistant Professor at the Department of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawaii Hilo. His research work is focused on exploring applications of nanomedicine for the prevention and/or treatment of cancer, infectious diseases and inflammatory disorders. He received his M.Pharm., and Ph.D. in Pharmaceutics from Bombay College of Pharmacy, University of Mumbai, India. His doctoral work focused on the development of novel self-assembled lipid nanocarriers for improved oral delivery of drugs and natural products.
During Ph.D., he was also selected as a part of Institute of Chemical Technology team that represented India at the Indo‐UK Biotechnology YES (Young Entrepreneurship Scheme) at Oxford, United Kingdom. After graduation, he joined the Chemistry of Life Processes Institute, Northwestern University as a post-doctoral fellow. He received an additional post-doctoral training at the School of Pharmacy and Health Professions, Creighton University and at The Center for Nanomedicine at Johns Hopkins University School of Medicine. He received the Johns Hopkins Center for Nanomedicine research excellence award in 2016. He has 40 peer-reviewed publications and 1 book chapter to his credit. His research work has resulted in the filing of 4 US patents. .
Dr. Brian Aguado is currently an NIH and Burroughs Wellcome Fund postdoctoral fellow at the University of Colorado. His current research is focused on developing precision biomaterials for applications in personalized medicine. Brian completed his MS and PhD in biomedical engineering from Northwestern University and his BS degree in biomechanical engineering from Stanford University. He also obtained his certificate in Management for Scientists and Engineers from the Kellogg School of Management at Northwestern.
Brian is also a dedicated science communicator outside of the lab and seeks to engage underrepresented populations in the sciences. He has served as president of the Postdoctoral Association of Colorado, a seminar series coordinator for CU Café, and currently serves as the CU Boulder Representative for Project Bridge.
Dr. HYOWON (HUGH) LEE ▼
Assistant Professor of Biomedical Engineering, Weldon School of Biomedical Engineering
Hyowon (Hugh) Lee received his B.A. in neuroscience from Colorado College in 2004 and his M.S. and Ph.D. degrees in biomedical engineering from the University of California, Los Angeles, in 2008 and 2011, respectively. Before joining Purdue, he worked as a senior engineer for St. Jude Medical’s Implantable Electronics Systems Division where he focused on using advanced fabrication technologies to overcome manufacturing challenges associated with implantable electronic devices such as pacemakers, ICDs, DBS, and other neurostimulation devices.
At UCLA, he trained in the areas of neuroengineering and microfabrication to develop novel implantable magnetic microactuators for hydrocephalus patients. His current research interests include development and translation of implantable micro and nanosystemsfor neurological application, MEMS-cell interface for cancer research, and safety and reliability of implantable neurostimulation devices
Niren Murthy is a professor in the Department of Bioengineering at the University of California at Berkeley. Dr. Murthy’s laboratory is an interdisciplinary laboratory that focuses on the development of new materials for drug delivery and molecular imaging. Dr. Murthy received the NSF CAREER award in 2006, and the 2009 Society for Biomaterials Young Investigator Award. The Murthy laboratory has developed several new biomaterials for drug delivery and molecular imaging, such as the hydrocyanines.
Dr. Bianca Cerqueira ▼
Dr. Cerqueira is the Co-founder and President of NovoThelium, a biotechnology company developing a tissue based matrix for nipple regeneration after mastectomy. Dr. Cerqueira completed her Ph.D. in Biomedical Engineering at University of Texas Health Science Center at San Antonio/University of Texas at San Antonio, where her dissertation work investigated the ability of melatonin to ameliorate effects of chronic intermittent hypoxia (a model of sleep apnea) on stroke in rodents utilizing multimodal MRI including cASL f-MRI, resting CBF imaging, and diffusion weighted imaging. She also holds a certificate in Translational Science from UT Health San Antonio.
She has a Bachelor of Science in Physiology and Neurobiology from University of Maryland, where she began her career in science at Walter Reed Army Institute of Research in the Department of Casualty Research studying blood additive solutions.
Dr. Kimberly Hamad-Schifferli ▼
Associate Professor of Engineering, University of Massachusetts Boston
In 2015 she joined the University of Massachusetts Boston as an Associate Professor in the Department of Engineering. She received the Office of Naval Research Young Investigator Award (ONR YIP) in 2004 and the Ruth and Joel Spira Award for Distinguished Teaching in Engineering at MIT. She is a long-time member of the American Chemical Society, and has served on the Chair of the Biophysical Subdivision of the Physical Chemistry Executive Committee of the ACS. She is also a member of the Materials Research Society. Her work investigates the physical interface of nanoparticles with biomolecules, exploring the fundamental properties of nanoparticle-protein, nanoparticle- DNA interactions, and nanoparticle protein coronas, in addition to developing applications that exploit the interface for triggered release from gold nanoparticles and nanorods and rapid diagnostics for infectious disease that use gold and silver nanoparticles.